Anti Hypertension

There are many classes of anti hypertensives, which lower blood pressure by different means. Among the most important and most widely used medications are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta blockers. People with hypertension are at a higher risk for several other health complications such as stroke and heart disease.

Category:

Description

Anti-hypertensive drugs are used to decrease the level of blood pressure, different drug class of drugs with different mechanism of action exist in the market. The anti hypertensive market is increasing with increased patient pool mainly geriatric population and extensive research and growth for novel pipeline drug. The global anti hypertensive market show robust growth in forecast period, but it face threat of generalization and increased competition due to patent expiry.

Antihypertensives are a class of Drugs that are used to anti hypertension (high blood pressure). Anti hypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Evidence suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34%, of ischaemic heart disease by 21%, and reduce the likelihood of  dementia, heart failure and mortality from cardiovascular disease. There are many classes of anti hypertensives, which lower blood pressure by different means. Among the most important and most widely used medications are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta blockers.

Anti-hypertensive drugs Market research report identifies players like:
  • Novartis
  • Pfizer
  • Johnson & Johnson
  • Sanofi
  • Lupin
  • Ranbaxy Laboratories
  • Merck
  • AstraZeneca
  • Daiichi Sankyo Company Limited
  • Takeda Pharmaceutical

admin